SUSQUEHANNA INTERNATIONAL GROUP, LLP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,736,806
-51.1%
148,572
-43.8%
0.00%
-100.0%
Q2 2023$3,553,186
-50.6%
264,374
-39.1%
0.00%
-50.0%
Q1 2023$7,192,421
-22.8%
433,801
-13.4%
0.00%0.0%
Q4 2022$9,314,415
+186.3%
500,775
+97.5%
0.00%
+100.0%
Q3 2022$3,253,000
+678.2%
253,530
+325.5%
0.00%
Q2 2022$418,000
-54.8%
59,591
-46.6%
0.00%
Q1 2022$924,000
-59.3%
111,510
-66.7%
0.00%
Q4 2021$2,268,000
+83.6%
334,902
+43.7%
0.00%
Q3 2021$1,235,000
-58.8%
233,110
-55.2%
0.00%
Q2 2021$2,996,000
+226.0%
520,806
+161.3%
0.00%
Q1 2021$919,000
-9.0%
199,280
-34.3%
0.00%
Q4 2020$1,010,000
+18.8%
303,092
+5.9%
0.00%
Q3 2020$850,000
+28.2%
286,301
+99.5%
0.00%
Q2 2020$663,000
-36.6%
143,531
-47.2%
0.00%
Q1 2020$1,046,000
+33.9%
271,710
+30.5%
0.00%
Q4 2019$781,000
-65.0%
208,263
-50.5%
0.00%
-100.0%
Q3 2019$2,233,000
-66.1%
420,434
-75.5%
0.00%
Q2 2019$6,585,000
+526.5%
1,714,174
+731.7%
0.00%
Q1 2019$1,051,000
+783.2%
206,100
+232.0%
0.00%
Q4 2018$119,000
-88.0%
62,078
-76.4%
0.00%
Q3 2018$995,000
+233.9%
263,300
+176.3%
0.00%
Q2 2018$298,000
+136.5%
95,295
+80.8%
0.00%
Q1 2018$126,000
-57.7%
52,700
-30.8%
0.00%
Q4 2017$298,000
+204.1%
76,194
+97.4%
0.00%
Q3 2017$98,000
-76.0%
38,600
-74.0%
0.00%
Q2 2017$409,000
+549.2%
148,200
+148.9%
0.00%
Q4 2016$63,000
-28.4%
59,541
-26.0%
0.00%
Q3 2016$88,000
+10.0%
80,497
-28.3%
0.00%
Q2 2016$80,000
+110.5%
112,310
+252.8%
0.00%
Q1 2016$38,000
-39.7%
31,830
+23.4%
0.00%
Q4 2015$63,000
-11.3%
25,789
+9.6%
0.00%
Q3 2015$71,000
-82.2%
23,523
-75.7%
0.00%
Q2 2015$400,000
-74.3%
96,694
-73.1%
0.00%
-100.0%
Q1 2015$1,556,000
+681.9%
359,254
+437.3%
0.00%
Q4 2014$199,000
-8.7%
66,857
+2.1%
0.00%
Q3 2014$218,000
-37.2%
65,495
-52.2%
0.00%
Q2 2014$347,000137,0330.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders